The OncoKey SQ Hereditary Cancer Panel is a comprehensive next-generation sequencing (NGS)-based assay designed to detect hotspot mutations (single-nucleotide variants (SNVs) and insertions and deletions (indels)) from 37 targeted genes frequently mutated in human cancers.
This panel is intended to be used on the Sentosa® SX101 with Sentosa SX U-Prep Kit for buccal swab, saliva swab, whole saliva and whole blood samples in conjunction with Sentosa SQ301 and Sentosa ST401 instruments.
| Biomarkers | ||||
| APC | CDKN2A | MSH6 | RAD51D | TMEM127 |
| ATM | CHEK2 | MUTYH | RET | TP53 |
| BMPR1A | EPCAM | NBN | SDHAF2 | TSC1 |
| BRCA1 | FH | NF1 | SDHB | TSC2 |
| BRCA2 | FLCN | PALB2 | SDHC | VHL |
| BRIP1 | MAX | PMS2 | SDHD | |
| CDH1 | MLH1 | PTEN | SMAD4 | |
| CDK4 | MSH2 | RAD51C | STK11 | |
Supporting Clinical Research:
Providing Laboratory Efficiency:
| Attribute | OncoKey SQ Hereditary Cancer Panel | |||
| Regulatory Status | Research use only (RUO) | |||
| Number of Genes | 37 genes (868 amplicons) | |||
| DNA Input Requirement | 2 ng/PCR reaction | |||
| Median Coverage | ≥10x | |||
| Sample Throughput | 16 samples (including 1 system control) |
|||
| Hands-on Time | 2 hours | |||
| Turnaround Time | 3 days | |||
| Limit of Detection | 0.5 ng DNA Input/PCR reaction | |||
| Analytical Sensitivity | 93.18% | |||
| OncoKey SQ Hereditary Cancer Panel Flyer | RUO | EN |
| Product | Pack Size | Item Number |
|---|---|---|
| OncoKey SQ Hereditary Cancer Reagents (4x16) RUO | 4x16 | 300834 |
| Sentosa SQ OncoKey Solutions (4x16) RUO | 4x16 | 300693 |
| Sentosa SX U-Prep Kit (4) RUO | 4 | 300836 |
| VELA Analytics Software | 480175 |
For availability in your country, please contact your Vela Diagnostics sales representative. Availability is subject to country's regulatory approval.
For more product related documents, please contact us.